Cadila Healthcare Limited has informed the Exchange regarding a press release dated February 14, 2022, titled "Zydus gets 180 day shared exclusivity for Roflumilast Tablets".
Press Release Feb 14 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Feb 02 2022
- Press Release Jan 20 2022
- Press Release Dec 31 2021
- Press Release Dec 22 2021
- Press Release Dec 16 2021
Later from Zydus Lifesciences
- Press Release Feb 23 2022
- Press Release Mar 07 2022
- Press Release Mar 08 2022
- Press Release Mar 09 2022
- Press Release Mar 14 2022
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences